On Thursday, October 4, 2012, MD Becker Partners will host its Third Annual "Cancer Immunotherapy: A Long-Awaited Reality"Conference at the New York Academy of Medicine in New York City. This unique, single-day conference event unites founding visionary researchers, clinicians, business leaders, key investors, and other stakeholders to engage in discussions, exchange information, highlight opportunities, and showcase leading companies in the field of cancer immunotherapy.
To view the keynote address and select plenary sessions and panel discussions from last year's event, please visit the firm's new YouTube page at: www.youtube.com/mdbeckerpartners
A direct link to last year's keynote address by Axel Hoos, M.D., Ph.D., Co-Chairman of the Cancer Immunotherapy Consortium, is displayed below:
MD Becker Partners is a boutique management and strategy consulting firm focusing on both public and private companies in the life science industry. We also work with venture capitalists, institutional investors, and others that provide capital to these companies. As a strategic advisor and partner, they provide a full range of services to help our clients increase visibility, unlock stakeholder value and access resources to grow their business. To accomplish this, they integrate relations, strategy, and operational capabilities and apply them to carefully conceived and expertly enacted tactics. Visit their website to learn more at www.mdbpartners.com.